Media Releases

The story of Vazyme began in 2012, when the founders put together a dedicated, innovative team with a shared vision and started their journey. Over the past decade, Vazyme has grown from a small and unknown team to a public listed company with operations in over 60 countries and regions, and has been recognized by an increasing number of global partners. We are dedicated to empowering our customers, advancing scientific research, and improving human health.

University laboratory: Where Vazyme's journey began

Dr. Cao Lin, the founder of Vazyme, was a passionate university professor with a deep interest in biology. He was obsessed with exploring new experimental methods and reagents. One evening, while alone in the lab, Dr. Cao was busy organizing documents on his desk. He was always the first to arrive and the last to leave the lab. But that night, he felt a bit down. Going through the reagent purchase records for the recent month, he noticed some problems: high prices, a long delivery cycle, and a lack of technical support. With limited funding, he had to think twice before every reagent purchase, which hindered his research progress. Dr. Cao knew that he was not the only one facing these problems and he could try to solve them and make lab work easier.

Dr. Cao Lin and a group of like-minded friends embarked on their adventure in this small lab in Nanjing.

Dr. Cao believed that only in a competitive market could he put his knowledge into practice. With the aim of developing innovative reagents and enzyme-based solutions to solve complex technical challenges, Dr. Cao and his colleagues decided to start a business together. In 2012, they founded Vazyme, embarking on a journey of biological research.

In the beginning, Dr. Cao’s team only had a few members. They worked hard in the lab, developing new reagents and testing and improving their performance, with the goal of providing better reagents for customers. After years of efforts, Vazyme continued to grow and gained recognition from partners including university laboratories and research institutions. Listed on the STAR Market of the Shanghai Stock Exchange in November 2021, Vazyme is now one of the few innovative R&D companies capable of developing upstream technologies and manufacturing end products.

Up to now, Vazyme has developed more than 200 types of genetically engineered recombinant enzymes, each of which evolves into hundreds to thousands of mutant variants, over 1,000 key raw materials such as high-performance antigens and monoclonal antibodies, as well as over 1,000 end products, which are widely applied in fields including scientific research, NGS, IVD, pharmaceutical and vaccine research and development, and animal healthcare. Our solutions and services are based on four self-developed technology platforms: Protein Directed Modification & Evolution Platform, High Performance Antibody Discovery Platform (Based on Single B Cell), Multi-system Recombinant Protein Preparation Platform, and Quantum Dot Modified Coupling and Multi-index Joint Inspection Technology Platform. Our reliable products have gained the trust of over 10,000 clients worldwide, including 1,000+ scientific research institutions, 700+ high-throughput sequencing service companies, 700+ molecular diagnostic reagent manufacturers, 200+ pharmaceutical companies and CRO companies, and 2,200+ hospitals, third-party testing and medical examination institutions.

Diversified collaboration: Vazyme's global expansion

Founded in a room covering just 106 square meters at No. 78 Shuangbai Lane, Nanjing, Vazyme has been burgeoning all the way. Thanks to the efforts of Dr. Cao and his team, Vazyme now possesses a modern R&D base spanning over 50,000 square meters in Red Maple Hi-tech Industry Park, Nanjing, PRC. The recognition from our partners in the Chinese market inspired Dr. Cao to bring Vazyme’s high-performance products and technologies to the global stage and serve people worldwide.

In 2015, Dr. Cao attended an international science and technology conference where he met experts and entrepreneurs in the field of biology from different countries. They shared research achievements, technological innovations, and successful market applications. This experience made Dr. Cao realize the global trend in scientific research and the immense market potential. In the same year, Vazyme established an international business department and ventured into global markets, marking a key move in its globalization strategy. Soon after, a clinical laboratory in the Philippines approached Vazyme and expressed its significant interest in the company’s Nucleic Acid Extraction Reagents, as well as POCT test kits and instruments. They believed that Vazyme’s products could make it easier and more efficient to obtain accurate testing results, and hoped to forge a long-term partnership with us. We realized that international cooperation is essential to addressing global challenges in life science and in vitro diagnostics, and we firmly believed that high-quality products and innovative technologies should benefit everyone, regardless of national borders. This belief became our mission.

To this end, Vazyme started to engage in international operations and collaborations. We built technical support teams worldwide, fostering partnerships with biomedical research institutions in Europe, the United States, Southeast Asia, etc., to share our achievement and expertise in life science and IVD. During the COVID-19 pandemic, we devoted substantial resources and donated reagents to support hospitals, communities, and laboratories worldwide. Today, we focus more on public welfare, with a commitment to making greater contributions to human health. In addition, we have ventured into exploratory business areas, including animal quarantine terminal reagents, lab consumables, lab instruments, and microfluidic chips, to ensure that our company continues to provide valuable services to our customers.

“Only by engaging directly with customers can we understand their needs and quickly enhance our products and services.” Therefore, we have established offices worldwide to better serve local customers. We have also set up global warehouses and adopted cold-chain logistics to ensure timely delivery of high-quality products. We hope these initiatives could help us do more for the world.

Under Dr. Cao's leadership and his team's continued hard work, Vazyme has attracted exceptional talents and gained the trust of partners worldwide. “We still face major challenges in improving human health. Nevertheless, we remain committed to empowering our partners and digging deeper into life science, IVD, and bio-medicine. Together, we will conquer major diseases and enhance the overall well-being of humanity,” said Dr. Cao.